Phenotypic variability to medication management: an update on fragile X syndrome.

"Declarations Ethics approval and consent to participateThis work was approved by the Institutional Biomedical Ethics Committee of Umm Al-Qura University under the declaration of the National Committee of Biomedical Ethics at King Abdulaziz City for Sciences and Technology (KACST) (http://bioethics.kacst.edu.sa/About.aspx?lang=en-US). Consent for publicationWritten informed consent was obtained from the parents of all study participants to publish the results. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding This work was technically and financially supported by the Batterjee Medical College, Jeddah, Saudi Arabia for publishing this work."